AMGEN INC — Director's Dealing 2022

Aug 20, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AMGEN INC (AMGN)
CIK: 0000318154
Period of Report: 2022-08-18

Reporting Person: ECKERT ROBERT (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-08-18	Common Stock	S	6600	$248.9966	Disposed	21184	Direct

Footnotes

F1: The price reported is an average price. The prices ranged from $248.73 to $249.19 per share. Full information regarding the number of shares purchased at each separate price within such range is available upon request by the SEC staff, the issuer or a security holder of the issuer.

F2: These shares include 2,008 Dividend Equivalents (DEs) granted pursuant to the Director Program and subject to a qualifying dividend reinvestment plan. DEs are credited on the director's vested but deferred Restricted Stock Units and are paid out in shares of the Company's Common Stock on a one-to-one basis along with a cash payment for any remaining fractional share amount.